SIGN UP and get a FREE SHIPPING for the first order exceeding 200$.


1 x 3.0 mg

129.99 129.99 USD 129.99


4.6 7
5 X
126.09 / per pack
10 X
122.19 / per pack
20 X
118.29 / per pack
30 X
114.39 / per pack

This combination does not exist.

    Saxenda Liraglutide 

    Saxenda is a liraglutide-based product for appetite control and weight loss. This product was developed by the company to effectively combat excessive fatty tissue for patients with a high body mass index and in pre-obesity states. Designed to be administered daily for an extended period of time (1 to 3 years), the product provides effective fat percentage reduction in the first year of application and allows keeping a low weight for a long period of time. The main active component of the product is a natural compound - liraglutide, which acts as a hormone, reducing appetite and hunger. Thus, together with the correction of the diet plan and physical activity, the product is able to effectively normalize the body mass index and contribute to the overall improvement of the patient's condition.

    Benefits of Saxenda: 

    • can be administered at any convenient place and time interval, since it is compact and has optimal storage conditions
    • the product is available in a convenient injection pen form in which the required product dose can be adjusted for injection
    • effective in the correction of pre-obesity and obesity conditions, since it regulates hormonal metabolism and reduces appetite
    • might demonstrate significant results in combating obesity together with a proper diet plan
    • can be used in combination with medicines based on herbal ingredients
    • may be recommended for adolescents from the age of 12 with critical body mass index

    Scope of Saxenda:

    • control of appetite 
    • management of excessive fat tissue in the abdomen, upper arms and thighs areas 
    • correction of pre-obesity and obesity conditions 
    • normalization of body mass index




    Liraglutide, 3 mg

    Period of biodegradation

    up to 36 months

    Depth of introduction

    subcutaneous injection


    1 syringe


    3 mg

    Product type

    injectable product

    Application zone

    arms,belly,abdomen,internal thigh

    Indications for use

    reduction of body volumes,reduction of subcutaneous fat streak


    The product has contraindications and can only be used when prescribed by an appropriate specialist with a medical license.


    Novo Nordisk Inc., Denmark

    Saxenda injectable based on liraglutide to combat obesity.

    Your Dynamic Snippet will be displayed here... This message is displayed because you did not provided both a filter and a template to use.